Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 16, 2021
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
Mon, February 15, 2021
[ Mon, Feb 15th 2021
] - WOPRAI
Fri, February 12, 2021
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
Mike Matson Maintained (BSX) at Strong Buy with Increased Target to $46 on, Feb 12th, 2021
Mike Matson of Needham, Maintained "Boston Scientific Corporation" (BSX) at Strong Buy with Increased Target from $43 to $46 on, Feb 12th, 2021.
Mike has made no other calls on BSX in the last 4 months.
There are 3 other peers that have a rating on BSX. Out of the 3 peers that are also analyzing BSX, 0 agree with Mike's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mike
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $43 on, Thursday, February 4th, 2021
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $43 on, Tuesday, December 15th, 2020
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $41 on, Wednesday, November 18th, 2020
